BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22686526)

  • 1. Ontogeny of oral drug absorption processes in children.
    Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental models for predicting drug absorption and metabolism.
    Alqahtani S; Mohamed LA; Kaddoumi A
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series).
    Pang KS
    Drug Metab Dispos; 2003 Dec; 31(12):1507-19. PubMed ID: 14625347
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of gastric bypass surgery on drug absorption and pharmacokinetics.
    Brocks DR; Ben-Eltriki M; Gabr RQ; Padwal RS
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1505-19. PubMed ID: 22998066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile salts and their importance for drug absorption.
    Holm R; Müllertz A; Mu H
    Int J Pharm; 2013 Aug; 453(1):44-55. PubMed ID: 23598075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ; Kim JE; Kim DD; Yoon IS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption.
    del Amo EM; Heikkinen AT; Mönkkönen J
    Eur J Pharm Sci; 2009 Feb; 36(2-3):200-11. PubMed ID: 19063964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why we need proper PBPK models to examine intestine and liver oral drug absorption.
    Chow EC; Pang KS
    Curr Drug Metab; 2013 Jan; 14(1):57-79. PubMed ID: 22935069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.
    Cao X; Gibbs ST; Fang L; Miller HA; Landowski CP; Shin HC; Lennernas H; Zhong Y; Amidon GL; Yu LX; Sun D
    Pharm Res; 2006 Aug; 23(8):1675-86. PubMed ID: 16841194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality.
    Sun J; Miller JM; Beig A; Rozen L; Amidon GL; Dahan A
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):313-23. PubMed ID: 21235283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
    Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
    AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental pharmacokinetics.
    van den Anker JN; Schwab M; Kearns GL
    Handb Exp Pharmacol; 2011; 205():51-75. PubMed ID: 21882105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine gastrointestinal physiology: Breeds variations that can influence drug absorption.
    Oswald H; Sharkey M; Pade D; Martinez MN
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):192-203. PubMed ID: 26409436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption sites of orally administered drugs in the small intestine.
    Murakami T
    Expert Opin Drug Discov; 2017 Dec; 12(12):1219-1232. PubMed ID: 28920464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational oral absorption simulation of free base drugs.
    Sugano K
    Int J Pharm; 2010 Oct; 398(1-2):73-82. PubMed ID: 20655999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of proteins by biodegradable nanoparticles.
    Bakhru SH; Furtado S; Morello AP; Mathiowitz E
    Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model.
    Pang KS; Chow EC
    Drug Metab Dispos; 2012 Oct; 40(10):1869-77. PubMed ID: 22745334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.